Today, Germany marked its entry as the ninth nation to authorize the recreational use of cannabis.
Today, Germany marked its entry as the ninth nation to authorize the recreational use of cannabis.
Cellular Goods Plc (LSE: CBX), a company specializing in developing next-generation skincare and wellness products, is pleased to announce that the Company is to change its name to Cel AI PLC. The Company
After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
Chill Brands Group PLC (LSE: CHLL, OTCQB: CHBRF) has recently declared its intent to enlarge the Chill.com product marketplace via a newly inked agreement.
Shares of Chill Brands Group PLC (LSE: CHLL, OTCQB: CHBRF) shot up by over 17% on Monday after the firm announced agreements with specialized carriers to distribute nicotine-free vapour products
Cellular Goods (LSE: CBX), a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that it has entered into a contract with
Hellenic Dynamics Plc (LSE: HELD) has inked a five-year deal with ELGO-DIMITRA, an Institute of Plant Breeding and Genetic Resources located in Greece, to collaborate on research and projects. ELGO-DIMITRA
Love Hemp, the struggling cannabis supplement company, announced last night that administrators were appointed.
Some marijuana users claim that it makes them feel numb. However, the UK’s newest cannabis companies, it is having the opposite effect.
Hellenic Dynamics could be at the forefront of Europe’s growing multi-billion-euro medical cannabis sector. The European cannabis market is expected to reach €37 billion by 2027, twice the size of
Hellenic Dynamics could be at the forefront of Europe’s growing multi-billion-euro medical cannabis sector. The European cannabis market is expected to reach €37 billion by 2027, twice the size of
Hellenic Dynamics could be at the forefront of Europe’s growing multi-billion-euro medical cannabis sector. The European cannabis market is expected to reach €37 billion by 2027, twice the size of